Clinical Trial Update: Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating acute neuroendocrine response to intravenous diclofenac sodium in patients with hypopituitarism; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopituitarism

Drugs mentioned

• DICLOFENAC SODIUM (DICLOFENAC SODIUM)

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Hypopituitarism | Phase 4 | Status: COMPLETED